Heart Disease Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heart Bypass Surgery
Scientists at San Francisco General Hospital detail research in heart bypass surgery
July 6th, 2008
"Objectives The aim of this post hoc analysis from the TNT (Treating to New Targets) trial is to determine whether patients with previous coronary artery bypass grafting (CABG) surgery achieved clinical benefit from intensive low-density lipoprotein (LDL)-cholesterol lowering. The development and progression of atherosclerosis is accelerated in coronary venous bypass grafts," investigators in the United States report. " A total of 10,001 patients with documented coronary disease, including 4,654 with previous CABG, were randomized to atorvastatin 80 or 10 mg/day and were followed for a median of 4.9 years. The primary end point was the occurrence of a first major...
Source: Heart Disease Weekly (2008-07-06)
|
